EX-23.1 3 tm2140561_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

 

Consent of Independent Registered Public Accounting Firm

 

Avenue Therapeutics, Inc.

New York, New York

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-224276) and Form S-8 (No. 333-219972) of Avenue Therapeutics, Inc. of our report dated March 31, 2021, relating to the financial statements which appears in this Annual Report on Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.

 

 

/s/ BDO USA, LLP 

 

New York, New York

March 31, 2021